A drug interaction study investigating the effect of Rifabutin on the pharmacokinetics of Maraviroc in healthy subjects.
Effects of steady-state rifabutin on the pharmacokinetics of steady-state maraviroc were investigated in fourteen healthy adult female and male volunteers.Maraviroc 300 mg twice daily (BID) was given orally with food for fifteen days.On day six, rifabutin 300 mg once daily Wired Mouse (QD, P.O.) was added to the regimen.Formal pharmacokinetic (PK)